Inovio Pharmaceuticals, Inc.

NASDAQ:INO

1.84 (USD) • At close December 20, 2024
Bedrijfsnaam Inovio Pharmaceuticals, Inc.
Symbool INO
Munteenheid USD
Prijs 1.84
Beurswaarde 66,424,000
Dividendpercentage 0%
52-weken bereik 1.74 - 14.75
Industrie Biotechnology
Sector Healthcare
CEO Dr. Jacqueline E. Shea Ph.D.
Website https://www.inovio.com

An error occurred while fetching data.

Over Inovio Pharmaceuticals, Inc.

Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA sequence of the target

Vergelijkbare Aandelen

IDEAYA Biosciences, Inc. logo

IDEAYA Biosciences, Inc.

IDYA

25.61 USD

Accolade, Inc. logo

Accolade, Inc.

ACCD

3.48 USD

MiMedx Group, Inc. logo

MiMedx Group, Inc.

MDXG

9.1 USD

Agenus Inc. logo

Agenus Inc.

AGEN

2.83 USD

Centessa Pharmaceuticals plc logo

Centessa Pharmaceuticals plc

CNTA

17.16 USD

Leafly Holdings, Inc. logo

Leafly Holdings, Inc.

LFLY

1.62 USD

Tarsus Pharmaceuticals, Inc. logo

Tarsus Pharmaceuticals, Inc.

TARS

52.91 USD

AxoGen, Inc. logo

AxoGen, Inc.

AXGN

15.64 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)